Self-assembly and self-delivery nanodrug of bortezomib: a simple approach to achieve the trade-off between functionality and druggability

J Mater Chem B. 2019 Dec 21;7(47):7490-7493. doi: 10.1039/c9tb02174d. Epub 2019 Nov 25.

Abstract

Bortezomib, dietary tannic acid and an FDA-approved excipient poloxamer were used as building blocks without any chemical syntheses and modifications to construct a dynamic self-delivery nanodrug with high drug loading, outstanding stability, tunable size and pH-controlled release. This strategy with high druggability, reproducibility and productivity might be desirable and useful for pharmaceutical formulations of bortezomib.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials / chemistry
  • Biocompatible Materials / pharmacology
  • Bortezomib / chemistry*
  • Bortezomib / metabolism
  • Cell Survival / drug effects
  • Drug Carriers / chemistry*
  • Drug Liberation
  • Humans
  • Hydrogen-Ion Concentration
  • MCF-7 Cells
  • Nanoparticles / chemistry*
  • Particle Size
  • Poloxamer / chemistry
  • Poloxamer / pharmacology
  • Proteasome Inhibitors / chemistry
  • Proteasome Inhibitors / metabolism
  • Tannins / chemistry
  • Tannins / pharmacology

Substances

  • Biocompatible Materials
  • Drug Carriers
  • Proteasome Inhibitors
  • Tannins
  • Poloxamer
  • Bortezomib